Introduction {#Sec1}
============

Shockable rhythms, including ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT) on the initial electrocardiography (ECG), have long been recognized as key factors in promoting favorable neurological outcomes in cardiac arrest (CA) \[[@CR1]--[@CR3]\]. Substantial studies have shown risk factors associated with clinical outcomes of patients who have initially shockable rhythms \[[@CR1], [@CR4]\], while less attention has been paid to initially nonshockable rhythms, such as pulseless electrical activity (PEA) and asystole \[[@CR5]\]. However, the number of patients with initially nonshockable rhythms is greater than those with shockable rhythms \[[@CR6], [@CR7]\]. Furthermore, patients with initial nonshockable rhythms have poorer prognoses \[[@CR8], [@CR9]\]. Thus, it is of great importance to study CA patients with initially nonshockable rhythms in detail to improve the fatality rate of CA patients \[[@CR5], [@CR10]\].

Initially nonshockable rhythms in CA patients can be converted to shockable rhythms through cardiopulmonary resuscitation (CPR) \[[@CR11], [@CR12]\]. It is believed that treatment for nonshockable rhythms should focus on increasing cardiac muscle perfusion and myocardial tissue excitability with CPR to attain a subsequent conversion to shockable rhythms, some of which can be treated effectively by defibrillation \[[@CR13]\]. However, Hallstrom et al. \[[@CR11]\] reported an association between subsequent shock delivery by emergency medical service (EMS) providers and decreased hospital survival, which has led to controversy. Subsequently, three studies \[[@CR14]--[@CR16]\] on this topic showed results in contradiction to the report from Hallstrom et al. \[[@CR11]\].

More recently, Thomas et al. \[[@CR12]\] studied risk factors of survival in patients with initially nonshockable rhythms and reported no significant association between subsequent EMS shock deliveries and increased hospital survival, while Goto et al. \[[@CR17]\], in contrast, reported that subsequent shock delivery was significantly associated with increased 1-month favorable neurological outcome in patients with initially nonshockable rhythms. Despite the findings of these six studies on initially nonshockable rhythms \[[@CR11], [@CR12], [@CR14]--[@CR17]\], whether shock delivery during EMS resuscitation is associated with altered clinical outcomes in CA patients is still unclear. In addition, few reports have studied the etiology of CA and intervals between CPR and first shock delivery by EMS providers in patients with initially nonshockable rhythms in detail.

Therefore, we first tested for an association between subsequent shock delivery during EMS resuscitation and altered 1-month neurological outcomes in patients with initially nonshockable rhythms as a primary analysis. We further investigated factors associated with the presence of subsequent shock delivery, particularly regarding the etiology of CA, using multivariate regression analysis. We also evaluated the association of the interval between initiation of CPR and EMS shock with clinical outcomes. This study used a large, multicenter cohort collected for the Survey of Survivors after Out-of-hospital Cardiac Arrest in the Kanto Region (SOS-KANTO) 2012 Study Group; data from this cohort were prospectively collected by EMS personnel and hospital staff.

Materials and methods {#Sec2}
=====================

Study design {#Sec3}
------------

The SOS-KANTO 2012 study was prospectively conducted to accumulate prehospital and inhospital records for CA patients in the Kanto region, including Tokyo Prefecture, Japan, with the support of the Kanto Regional Group of the Japanese Association for Acute Medicine \[[@CR18]\]. The SOS-KANTO 2012 study included 16,452 CA patients from 67 emergency medical centers between January 2012 and March 2013. The relevant institutional review boards of all institutions approved the study (see Additional file [1](#MOESM1){ref-type="media"} for details). The review boards waived the need for written informed consent.

Patients {#Sec4}
--------

The current study included adult CA patients (≥18 years of age) who fit the following criteria: presented with an initial EMS-monitored nonshockable rhythm (PEA or asystole), received CPR administered by EMS providers, and were subsequently transported to one of the participating institutions. Exclusion criteria were as follows: absence of data regarding inclusion criteria or main outcomes (i.e., initially EMS-monitored ECG, EMS defibrillation data, and 1-month neurological outcomes); receipt of public-access defibrillation; onset of CA subsequent to the arrival of paramedics or at the hospital; transfer from another hospital; and no treatment performed at the participant hospital without the achievement of return of spontaneous circulation (ROSC). A total of 16,452 CA patients were enrolled in the SOS-KANTO 2012 study (Fig. [1](#Fig1){ref-type="fig"}). Of these, 13,597 adult patients had initially nonshockable rhythms. Of these, 2116 patients met the exclusion criteria, and thus 11,481 patients were evaluated in this study (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Flow diagram of the study population. A total of 16,452 CA patients were enrolled in the SOS-KANTO 2012 study. Of these, 13,597 adult patients had initially nonshockable rhythms. Of these, 11,481 patients were evaluated in this study. Of these, 10,960 patients received no shock (Subsequently Not Shocked group) and 521 patients received shock(s) during EMS resuscitation (Subsequently Shocked group). *1-month good recovery* survival with favorable neurological outcome defined as Cerebral Performance Category of 1 or 2 at 1 month after CA, *EMS* emergency medical service, *ROSC* return of spontaneous circulation

Data collection and definition {#Sec5}
------------------------------

EMS providers collected prehospital information in the standardized Utstein style, including age, sex, location, witnessed arrest, bystander CPR, call--response interval, initial cardiac rhythms monitored by EMS providers, and shock deliveries by EMS providers. We defined rhythm conversion of nonshockable rhythms to VF/ pulseless VT during EMS resuscitation when EMS providers delivered shock(s) for patients who had initially nonshockable rhythms; we used shock delivery as a surrogate indicator of conversion \[[@CR11], [@CR12], [@CR14]--[@CR17]\]. The call--response interval was defined as the interval from receipt of a call by emergency response dispatchers to the time when the emergency response vehicle came to a stop. Shock delivery time was defined as the interval between the initiation of CPR by EMS providers and the time of first shock delivery by EMS providers.

Patients who had initially nonshockable rhythms and subsequently received shock(s) during EMS resuscitation were assigned to the "Subsequently Shocked" group, while other patients who did not receive subsequent shock by EMS providers were assigned to the "Subsequently Not Shocked" group. EMS providers used semiautomated external defibrillators to analyze the rhythm, and if a shock was indicated it was delivered \[[@CR19]\].

Physicians were responsible for treating the patient-determined causes of CA, including cardiac and noncardiac (asphyxia, trauma, aortic disease, drawing, cerebrovascular disease, drug overdose, and others). The institutional researchers collected information that included ROSC during resuscitation by EMS providers or physicians, 24-hour survival, 1-month survival, and neurological outcomes. Neurological outcomes were evaluated using the Cerebral Performance Categories (CPCs) \[[@CR20]\]; responses were scored as follows: CPC 1, good cerebral performance; CPC 2, moderate cerebral disability; CPC 3, severe cerebral disability; CPC 4, coma/vegetative state; and CPC 5, death. Favorable neurological outcome was defined as CPC 1 or 2.

Statistical analysis {#Sec6}
--------------------

The primary outcome variable was 1-month survival with a favorable neurological outcome. For the primary analysis, we assessed differences in 1-month favorable neurological outcomes by subsequent shock delivery using a multivariate logistic regression to allow for adjustment for potential confounding factors reported previously, including age, sex, public location, witnessed arrest, bystander CPR, call--response interval, initial PEA rhythm, and cardiac etiology as covariates \[[@CR11], [@CR12], [@CR14]--[@CR17]\]. For the secondary analysis, we used a multivariate logistic regression to assess factors associated with the presence of subsequent shock. In addition, the frequency of ROSC, 24-hour survival, 1-month survival, and 1-month favorable neurological outcome in subsequent shock patients were compared by interval of EMS shock delivery. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated. The level of significance was set at α = 0.05 with a two-tailed test. Analyses were performed using SPSS (version 21; SPSS, Chicago, IL, USA) statistical software packages.

Results {#Sec7}
=======

Of 11,481 patients who had initially nonshockable arrest rhythms monitored by EMS providers, 521 patients received shock(s) during EMS resuscitation (Subsequently Shocked group) and 10,960 patients received no shock (Subsequently Not Shocked group) (Table [1](#Tab1){ref-type="table"}). Patients who received subsequent shocks were younger than patients who were not shocked. The frequencies of male sex, witnessed arrest, initial PEA rhythms, and cardiac etiology in patients who were shocked were higher compared with those who were not shocked (Table [1](#Tab1){ref-type="table"}).Table 1Baseline characteristic of patients who had initially nonshockable arrest rhythmsSubsequentlySubsequentlyNot Shocked^a^Shocked^b^(*n* = 10,960)(*n* = 521)*P* valueAge (years)71.2 (16.9)68.0 (16.5)\<0.0001Sex (% male)58.565.30.0024Public location (%)18.820.90.24Witnessed arrest (%)42.254.5\<0.0001Bystander CPR (%)30.728.10.21Call--response interval (minutes)8.0 (3.6)8.2 (3.8)0.18Initial rhythm PEA (*n* (%))2455 (22.4)229 (44.0)\<0.0001Initial rhythm asystole (*n* (%))8505 (77.6)292 (56.0)\<0.0001Shock delivery time (minutes)--13.0 (9.8)N/AEtiology (*n* (%)) Cardiac4748 (43.3)331 (63.5)\<0.0001 Noncardiac6212 (56.7)190 (36.5) Asphyxia1469(13.4)39 (7.5) Trauma928 (8.5)11 (2.1) Aortic disease569 (5.2)24 (4.6) Drowning447 (4.1)12 (2.3) Cerebrovascular disease267 (2.4)11 (2.1) Drug overdose72 (0.7)3 (0.6) Others or unknown2460 (22.2)90 (17.3)Data are mean (standard deviation) for continuous variables. *P* values calculated using the *t* test and the chi-square test^a^Patients who had initially nonshockable rhythms and received no shock(s) during EMS resuscitation^b^Patients who had initially nonshockable arrest rhythms and subsequently received shock(s) owing to conversion to shockable rhythms during EMS resuscitation*CPR* cardiopulmonary resuscitation, *EMS* emergency medical service, *N/A* not available, *PEA* pulseless electrical activity

In the univariate analysis, patients in the Subsequent Shock group had significantly increased frequency of ROSC, 24-hour survival, 1-month survival, and favorable neurological outcomes compared with the Subsequent Not Shocked group (*P* \<0.0001) (Table [2](#Tab2){ref-type="table"}). In the primary analysis of this study population with initially nonshockable rhythms, patients who had subsequent shocks by EMS providers had significantly increased 1-month favorable neurological outcomes compared with those who received no subsequent shock in a multivariate logistic regression analysis adjusting for potential confounding factors, including age, sex, public location, witnessed arrest, bystander CPR, call--response interval, initial PEA rhythm, and cardiac etiology (adjusted *P* = 0.0020; OR, 2.78; 95 % CI, 1.45--5.30) (Table [3](#Tab3){ref-type="table"}).Table 2Clinical outcomes between the Subsequently Shocked and Not Shocked groupsSubsequentlySubsequentlyNot Shocked^a^Shocked^b^Odds ratio(*n* = 10,960)(*n* = 521)(95 % CI)*P* valueROSC2891 (26.4)185 (35.5)1.54 (1.28--1.86)\<0.000124-hour survival700 (6.4)59 (11.3)1.87 (1.41--2.48)\<0.00011-month survival187 (1.7)25 (4.8)2.90 (1.89--4.45)\<0.00011-month good recovery^c^52 (0.5)14 (2.7)5.79 (3.19--10.5)\<0.0001Data presented as number (percentage). *P* values calculated using chi-square test^a^Patients who had initially nonshockable rhythms and received no shock(s) during EMS resuscitation^b^Patients who had initially nonshockable arrest rhythms and subsequently received shock(s) owing to conversion to shockable rhythms during EMS resuscitation^c^Survival with favorable neurological outcome defined as Cerebral Performance Category of 1 or 2 at 1 month after cardiac arrest*CI* confidence interval, *EMS* emergency medical service, *ROSC* return of spontaneous circulationTable 3Multivariate analysis for factors associated with favorable neurological outcome at 1 month after cardiac arrest in patients with initially nonshockable rhythmsOdds ratio (95 % CI)*P* valueAge (per year)0.97 (0.96--0.98)\<0.0001Male0.99 (0.58--1.69)0.97Public location1.54 (0.90--2.62)0.11Witnessed arrest1.30 (0.75--2.24)0.35Bystander CPR0.83 (0.47--1.48)0.54Call--response interval^a^ (per minute)0.91 (0.83--0.99)0.037Initial rhythm PEA11.3 (5.94--21.6)\<0.0001Cardiac etiology1.82 (1.07--3.09)0.028Subsequently shocked2.78 (1.45--5.30)0.0020*P* values calculated using a multivariate logistic regression^a^Shock delivery time was the interval from the initiation of CPR by EMS providers to the first shock delivery by EMS providers*CI* confidence interval, *CPR* cardiopulmonary resuscitation, *EMS* emergency medical service, *PEA* pulseless electrical activity

We next examined factors associated with the presence of subsequent shock. Younger age, witnessed arrest, having initial PEA rhythms, and cardiac origin of etiology were significantly associated with increased subsequent shock (Table [4](#Tab4){ref-type="table"}). In the Subsequently Shock group, the frequencies of patients with 24-hour survival, 1 month survival, and 1-month favorable neurological outcome significantly deceased over time, which is the interval from initiation of CPR to shock delivery (test for trend; 24-hour survival, *P* = 00032; 1-month survival, *P* = 0.013; 1-month favorable neurological outcome, *P* = 0.0002); while there was no difference in the frequencies of patients with ROSC over time (test for trend; *P* = 0.58) (Fig. [2](#Fig2){ref-type="fig"}). Patients with 1-month favorable neurological outcomes received subsequent shock deliveries within 9 minutes of initiation of CPR (Fig. [2](#Fig2){ref-type="fig"}).Table 4Multivariate analysis for factors associated with subsequent shock in emergency medical service resuscitation in patients with initial nonshockable rhythmsOdds ratio (95 % CI)*P* valueAge0.98 (0.97--0.98)\<0.0001Male0.85 (0.70--1.03)0.11Public location1.12 (0.89--1.41)0.34Witnessed arrest1.37 (1.12--1.66)0.0018Bystander CPR0.90 (0.73--1.10)0.30Call--response interval1.02 (1.00--1.04)0.13Initial rhythm PEA2.67 (2.19--3.25)\<0.0001Etiology Cardiac (reference)1 Asphyxia0.30 (0.21--0.43)\<0.0001 Trauma0.09 (0.05--0.18)\<0.0001 Aortic disease0.46 (0.29--0.71)0.00047 Drowning0.53 (0.29--0.95)0.0330 Cerebrovascular disease0.40 (0.22--0.75)0.0044 Drug overdose0.44 (0.14--1.42)0.17 Others or unknown0.47 (0.37--0.60)\<0.0001*P* values calculated using a multivariate logistic regression*CI* confidence interval, *CPR* cardiopulmonary resuscitation, *PEA* pulseless electrical activityFig. 2Clinical outcomes by interval between CPR and initial shock in subsequent shock patients. There were significant decreases in 24-hour survival, 1-month survival, and 1-month favorable neurological outcome according to the interval between initiation of cardiopulmonary resuscitation (*CPR*) and initial shock delivery by emergency medical service providers (*EMS*) in patients who received subsequent shock (ROSC, *P* = 0.58; 24-hour survival, *P* = 0.0032; 1-month survival, *P* = 0.013; 1-month good recovery, *P* = 0.0002). *1-month good recovery* survival with favorable neurological outcome defined as CPC of 1 or 2 at 1 month after CA. *P* values calculated using the chi-square test for trend. *1mo* 1-month, *24h* 24-hour, *ROSC* return of spontaneous circulation

Discussion {#Sec8}
==========

This study of initially nonshockable rhythms demonstrated that patients who received subsequent shock had increased 1-month favorable neurological outcomes compared with those who received no shock from EMS providers.

The association of subsequent shock deliveries with altered clinical outcomes in patients of initially nonshockable rhythms has been analyzed in six studies (Table [5](#Tab5){ref-type="table"}) \[[@CR11], [@CR12], [@CR14]--[@CR17]\]. Of four studies published prior to 2009, three studies reported an association of subsequent shock deliveries with favorable clinical outcomes \[[@CR14]--[@CR16]\], and one study reported the opposite result \[[@CR11]\]. More recently, Thomas et al. \[[@CR12]\] reported no significant association of subsequent shock delivery with survival to hospital discharge in patients with initially nonshockable rhythms (OR, 0.88; 95 % CI, 0.60--1.30). Goto et al. \[[@CR17]\] published findings that patients with subsequent shock deliveries had increased 1-month favorable neurological outcomes. Thus, of seven studies including the present work, five studies showed that subsequent shock delivery was associated with increased favorable clinical outcomes (Table [5](#Tab5){ref-type="table"}).Table 5Studies of subsequent shock in patients with initially nonshockable rhythmsHallstrom et al. \[[@CR11]\]Herlitz et al. \[[@CR14]\]Kajino et al. \[[@CR15]\]Olasveemgen et al. \[[@CR16]\]Thomas et al. \[[@CR12]\]Goto et al. \[[@CR17]\]SOS-KANTO Study Group \[[@CR18]\]Published year2007200820082009201320142015Sample size (*n*)73822,46512,3537536556569,93711,481Response time (minutes)6.0 ± 2.67 ^a^6.0 ± 2.37 (3--11) ^a^--7 (5--9)^a^8.2 ± 3.8Shock delivery time^b^ (minutes)21.0 ± 8.1--12.3 ± 6.9----20 (15--27)^a^13.0 ± 9.8CountryUSASwedenJapanNorwayUSAJapanJapanSubsequent shock (%)22.226.03.913.018.94.84.5Association of subsequent shock with outcomes^c^Unfavorable outcomesFavorable outcomesFavorable outcomesFavorable outcomesNo differenceFavorable outcomesFavorable outcomes^a^Data are median (interquartile range) for continuous variables^b^Shock delivery time was the interval from the initiation of CPR by EMS providers to the first shock delivery by EMS providers^c^Association of subsequent shock with increased unfavorable or favorable clinical outcome*CPR*, cardiopulmonary resuscitation, *EMS* emergency medical service, *SOS-KANTO*, survey of survivors after out-of-hospital cardiac arrest in the Kanto region

We assessed the association between the interval from the initiation of CPR by EMS providers to the first shock delivery and clinical outcomes. As shown in Fig. [2](#Fig2){ref-type="fig"}, frequencies of ROSC remained over 30 % after a 20-minute interval from the initiation of CPR by EMS providers to the first shock delivery in the subsequent shock group. However, frequencies of 1-month favorable neurological outcomes decreased over time. A previous study showed that receiving subsequent defibrillation earlier (\<20 minutes) rather than later (≥20 minutes) was associated with increased favorable outcomes for CA patients \[[@CR17]\]. Similarly, in the current study, patients with 1-month favorable neurological outcomes had received subsequent shock deliveries earlier rather than later (Fig. [2](#Fig2){ref-type="fig"}).

As shown in Table [5](#Tab5){ref-type="table"}, there are regional differences in the prevalence of subsequent shock deliveries in patients with initially nonshockable rhythms. The frequency of subsequent shock in Japan was lower than that in Europe, the United States (Table [5](#Tab5){ref-type="table"}), and Australia \[[@CR21]\]. EMS providers in Japan have an obligation to transfer out-of-hospital CA patients, except patients with decapitation, transection of the trunk, or postmortem changes such as rigor mortis, postmortem lividity, and cloudiness of the cornea \[[@CR22]\]. Different EMS systems may thus result in different frequencies of subsequent conversion from nonshockable to shockable rhythms across countries. Increased favorable outcomes in patients with subsequent shock were reported in Japan and Europe, while the opposite results were obtained from the United States, suggesting regional differences may be a considerable factor in understanding the association between subsequent shock and altered clinical outcomes.

We found that either younger age or initial PEA rhythms were associated with increased favorable neurological outcomes in patients with initially nonshockable rhythms (Table [4](#Tab4){ref-type="table"}). The association between younger age or initial PEA rhythms and increased favorable outcomes was observed in all six studies of initially nonshockable rhythms from different regions \[[@CR11], [@CR12], [@CR14]--[@CR17]\]. Age and initial PEA rhythms are therefore likely to be important outcome predictors across countries.

Thomas et al. \[[@CR12]\] hypothesized that the inconsistent association between subsequent shock and clinical outcome may be caused by different etiologies of CA. In a subsequent study, Goto et al. \[[@CR17]\] tested for an association of altered clinical outcomes with subsequent shock including presumed cardiac cause or not as a covariate, which was collected by EMS personnel; they reported an association between presumed cardiac cause and increased 1-month favorable outcomes (OR, 1.28; 95 % CI, 1.20--1.37). In their discussion, they also pointed out the insufficiency of relevant information to analyze etiologies more precisely owing to their prehospital-based dataset \[[@CR17]\]. Etiologies in the current study were precisely collected by physicians; cardiac etiology was significantly associated with increased 1-month favorable neurological outcome in initially nonshockable rhythms (*P* = 0.028; OR, 1.82; 95 % CI, 1.07--3.09) (Table [3](#Tab3){ref-type="table"}). Moreover, the cardiac etiology was significantly associated with increased prevalence of subsequent shock (Table [4](#Tab4){ref-type="table"}), suggesting that cardiac etiology is likely to be of importance in patients with initially nonshockable rhythms.

This study has some limitations. First, the integrity and validity of the data, unmeasured confounders, as well as ascertainment bias are potential limitations of our observational study. The use of uniform Utstein template data collection, which was developed by international experts, and the large sample size should minimize these potential sources of bias. Second, this study was hospital driven but was not a population-based study; therefore, our findings might not be representative of all hospitals or other local regions. However, the large number of participating hospitals should minimize this limitation. Fourth, as in previous studies \[[@CR11], [@CR12], [@CR14]--[@CR17]\], we tested for an association of altered clinical outcome with EMS shock delivery, which is a surrogate indicator of rhythm conversion of nonshockable rhythms to VF/ pulseless VT. In real-world emergency situations, there are inevitably some violations of protocol or just mistaken rhythm identifications. Even though the EMS providers used semiautomated external defibrillators during the EMS resuscitation, there was a very small possibility that inappropriate shocks were given. The significant association of altered clinical outcome with EMS shock in this study is thus not likely to prove the association of rhythm conversions with altered outcome.

Conclusions {#Sec9}
===========

In this study of CA patients with initially nonshockable rhythms, patients who received early defibrillation by EMS had increased 1-month favorable neurological outcomes. In patients with initially nonshockable rhythms, cardiac etiology, younger age, witnessed arrest, and initial PEA rhythms were associated with increased subsequent shock.

Key messages {#Sec10}
============

In this study of cases of initially nonshockable CA rhythms, patients who received subsequent shock by EMS providers had significantly increased 1-month favorable neurological outcomes compared with those who received no subsequent shock.Cardiac etiology was associated with the presence of subsequent shock and increased 1-month favorable neurological outcome in patients with initially nonshockable rhythms.
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===============

Additional file 1:**Presents a list of institutional review boards.** (PDF 77 kb)

CA

:   Cardiac arrest

CI

:   Confidence interval

CPC

:   Cerebral Performance Category

CPR

:   Cardiopulmonary resuscitation

ECG

:   Electrocardiography

EMS

:   Emergency medical service

OR

:   Odds ratio

PEA

:   Pulseless electrical activity

ROSC

:   Return of spontaneous circulation

SOS-KANTO

:   Survey of Survivors after Out-of-hospital Cardiac Arrest in the Kanto Region

VF

:   Ventricular fibrillation

VT

:   Ventricular tachycardia
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